Skip to search formSkip to main contentSkip to account menu

Transaction counts and value totals - year

Known as: year 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Seven-year (yr) follow-up of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC).
511Background: Retrospective data suggest that patients (pts) with small HER2+ cancers have more than just minimal risk of… 
2014
2014
Seven-Year (yr) Follow-up of Patients (pts) with Imatinib-Resistant or -Intolerant Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Receiving Dasatinib in Study CA180-034, Final Study Results
Background: Dasatinib is a potent BCR-ABL tyrosine kinase inhibitor (TKI) currently approved at 100 mg once daily (QD) as a first… 
2014
2014
THU0190 Better Clinical Responses Seen Early with the Loading Dose of Certolizumab Pegol are Maintained until One Year
Background Certolizumab pegol (CZP) has demonstrated rapid and sustained improvements in disease activity in Japanese patients… 
2011
2011
Axitinib second-line therapy for metastatic renal cell carcinoma (mRCC): Five-year (yr) overall survival (OS) data from a phase II trial.
4547 Background: Axitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1-3… 
2010
2010
Clinical and biological features predictive of survival after relapse of neuroblastoma: A study from the International Neuroblastoma (NB) Risk Group (INRG) Database.
9518 Background: In NB, most patients (pts) who relapse eventually die. Prognostic factors are used to stratify treatment at… 
2009
2009
The Space Elevator Feasibility Condition
The principle for the feasibility condition (FC) is that a Space Elevator must be able to lift its own weight fast enough – fast… 
2008
2008
Trends in mastectomy rates at the Mayo Clinic Rochester: Effect of surgical year and preoperative MRI
509 Background: Surgical treatment for early stage breast cancer (ca) includes mastectomy (mast) or lumpectomy. The influence of… 
2008
2008
Does interruption of imatinib (IM) in responding patients after three years of treatment influence outcome of patients with advanced GIST included in the BFR14 trial
10522 Background: We previously demonstrated that IM must not be interrupted after one year (yr) in responding patients (pts) and… 
Review
1997
Review
1997
Pulmonary Function in Jute Dust‐Exposed Workers: A Dose‐Response Relationship
Pulmonary Function in Jute Dust‐Exposed Workers: A Dose‐Response Relationship: Jie Chen, et ai. Department of Pneumoconiosis… 
1995
1995
792-4 Three Years Clinical and Quantitative Angiographic Follow-up After the Palmaz-Schatz Coronary Stent Implantation
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)